Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Conditions:   Cutaneous T-cell Lymphoma;   T-Prolymphocytic Leukemia;   T-Large Granulocytic Leukemia;   T-Lymphoblastic Leukemia/Lymphoma;   Peripheral T-Cell Lymphoma
Interventions:   Drug: Romidepsin;   Drug: Busulfan;   Drug: Fludarabine;   Procedure: Stem Cell Transplant;   Drug: Thymoglobulin
Sponsors:   M.D. Anderson Cancer Center;   Celgene Corporation
Recruiting - verified January 2017